| Application no. and date | 20754482.6 (espacenet) (Federated) (European Patent Register), 20200723 | | Patent/reg. no. and date | DK/EP 4003532, 20240904 | | Publication date | 20220601 | | Priority no. and date | US 201962878012 P, 20190724 | | EP pub. no. and date |
EP 4003532 20220601 | | Effective date | | | Applicant/owner | Constellation Pharmaceuticals, Inc., 470 Atlantic Avenue, Suite 1401
Boston, MA 02210, US | | Applicant ref. no. | 1724082 | | Inventor | GEHLING, Victor, S., 10 Ware Street
Rear Unit
Somerville, MA 02144, US,
BANDA, Alamelu, 1 Alden Ln
Winchester, MA 01890, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/4433 (2006.01) , A61P 35/00 (2006.01) , C07D 405/14 (2006.01) | | Title | KRYSTALLINSKE FORMER AF 7-CHLOR-2-(4-(3-METHOXYAZETIDIN-1-YL)CYCLOHEXYL)-2,4-DIMETHYL-N-((6-METHYL-4-(METHYLTHIO)-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)BENZO[D][1,3]DIOXOL-5-CARBOXAMID | | Int. application no. | US2020043178 | | Int. publication no. | WO2021016414 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
